The Activation of JAK/STAT3 Signaling and the Complement System Modulate Inflammation in the Primary Human Dermal Fibroblasts of PXE Patients

Previous studies revealed a link between inflammation and overactivation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling in syndromes associated with aging. Pseudoxanthoma elasticum (PXE), a rare autosomal-recessive disorder, arises from mutations in <i...

Full description

Bibliographic Details
Main Authors: Christopher Lindenkamp, Ricarda Plümers, Michel R. Osterhage, Olivier M. Vanakker, Judith Van Wynsberghe, Cornelius Knabbe, Doris Hendig
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/10/2673
_version_ 1797574568567635968
author Christopher Lindenkamp
Ricarda Plümers
Michel R. Osterhage
Olivier M. Vanakker
Judith Van Wynsberghe
Cornelius Knabbe
Doris Hendig
author_facet Christopher Lindenkamp
Ricarda Plümers
Michel R. Osterhage
Olivier M. Vanakker
Judith Van Wynsberghe
Cornelius Knabbe
Doris Hendig
author_sort Christopher Lindenkamp
collection DOAJ
description Previous studies revealed a link between inflammation and overactivation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling in syndromes associated with aging. Pseudoxanthoma elasticum (PXE), a rare autosomal-recessive disorder, arises from mutations in <i>ATP-binding cassette subfamily C member 6</i> (<i>ABCC6</i>). On a molecular level, PXE shares similarities with Hutchinson–Gilford progeria syndrome, such as increased activity of senescence-associated- beta-galactosidase or high expression of inflammatory factors. Thus, this study’s aim was the evaluation of activated STAT3 and the influence of JAK1/2-inhibitor baricitinib (BA) on inflammatory processes such as the complement system in PXE. Analysis of activation of STAT3 was performed by immunofluorescence and Western blot, while inflammatory processes and complement system factors were determined based on mRNA expression and protein level. Our results assume overactivation of JAK/STAT3 signaling, increased expression levels of several complement factors and high C3 protein concentration in the sera of PXE patients. Supplementation with BA reduces JAK/STAT3 activation and partly reduces inflammation as well as the gene expression of complement factors belonging to the C1 complex and C3 convertase in PXE fibroblasts. Our results indicate a link between JAK/STAT3 signaling and complement activation contributing to the proinflammatory phenotype in PXE fibroblasts.
first_indexed 2024-03-10T21:25:19Z
format Article
id doaj.art-44a0ddada541404e99cc3aedeb89eca3
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T21:25:19Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-44a0ddada541404e99cc3aedeb89eca32023-11-19T15:45:26ZengMDPI AGBiomedicines2227-90592023-09-011110267310.3390/biomedicines11102673The Activation of JAK/STAT3 Signaling and the Complement System Modulate Inflammation in the Primary Human Dermal Fibroblasts of PXE PatientsChristopher Lindenkamp0Ricarda Plümers1Michel R. Osterhage2Olivier M. Vanakker3Judith Van Wynsberghe4Cornelius Knabbe5Doris Hendig6Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyInstitut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyInstitut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyCenter for Medical Genetics, Ghent University Hospital, 9000 Ghent, BelgiumCenter for Medical Genetics, Ghent University Hospital, 9000 Ghent, BelgiumInstitut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyInstitut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyPrevious studies revealed a link between inflammation and overactivation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling in syndromes associated with aging. Pseudoxanthoma elasticum (PXE), a rare autosomal-recessive disorder, arises from mutations in <i>ATP-binding cassette subfamily C member 6</i> (<i>ABCC6</i>). On a molecular level, PXE shares similarities with Hutchinson–Gilford progeria syndrome, such as increased activity of senescence-associated- beta-galactosidase or high expression of inflammatory factors. Thus, this study’s aim was the evaluation of activated STAT3 and the influence of JAK1/2-inhibitor baricitinib (BA) on inflammatory processes such as the complement system in PXE. Analysis of activation of STAT3 was performed by immunofluorescence and Western blot, while inflammatory processes and complement system factors were determined based on mRNA expression and protein level. Our results assume overactivation of JAK/STAT3 signaling, increased expression levels of several complement factors and high C3 protein concentration in the sera of PXE patients. Supplementation with BA reduces JAK/STAT3 activation and partly reduces inflammation as well as the gene expression of complement factors belonging to the C1 complex and C3 convertase in PXE fibroblasts. Our results indicate a link between JAK/STAT3 signaling and complement activation contributing to the proinflammatory phenotype in PXE fibroblasts.https://www.mdpi.com/2227-9059/11/10/2673pseudoxanthoma elasticumJAK/STAT3complement systembaricitinib
spellingShingle Christopher Lindenkamp
Ricarda Plümers
Michel R. Osterhage
Olivier M. Vanakker
Judith Van Wynsberghe
Cornelius Knabbe
Doris Hendig
The Activation of JAK/STAT3 Signaling and the Complement System Modulate Inflammation in the Primary Human Dermal Fibroblasts of PXE Patients
Biomedicines
pseudoxanthoma elasticum
JAK/STAT3
complement system
baricitinib
title The Activation of JAK/STAT3 Signaling and the Complement System Modulate Inflammation in the Primary Human Dermal Fibroblasts of PXE Patients
title_full The Activation of JAK/STAT3 Signaling and the Complement System Modulate Inflammation in the Primary Human Dermal Fibroblasts of PXE Patients
title_fullStr The Activation of JAK/STAT3 Signaling and the Complement System Modulate Inflammation in the Primary Human Dermal Fibroblasts of PXE Patients
title_full_unstemmed The Activation of JAK/STAT3 Signaling and the Complement System Modulate Inflammation in the Primary Human Dermal Fibroblasts of PXE Patients
title_short The Activation of JAK/STAT3 Signaling and the Complement System Modulate Inflammation in the Primary Human Dermal Fibroblasts of PXE Patients
title_sort activation of jak stat3 signaling and the complement system modulate inflammation in the primary human dermal fibroblasts of pxe patients
topic pseudoxanthoma elasticum
JAK/STAT3
complement system
baricitinib
url https://www.mdpi.com/2227-9059/11/10/2673
work_keys_str_mv AT christopherlindenkamp theactivationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT ricardaplumers theactivationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT michelrosterhage theactivationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT oliviermvanakker theactivationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT judithvanwynsberghe theactivationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT corneliusknabbe theactivationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT dorishendig theactivationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT christopherlindenkamp activationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT ricardaplumers activationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT michelrosterhage activationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT oliviermvanakker activationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT judithvanwynsberghe activationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT corneliusknabbe activationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients
AT dorishendig activationofjakstat3signalingandthecomplementsystemmodulateinflammationintheprimaryhumandermalfibroblastsofpxepatients